NHS policy for 2024/25: strategy and engagement in a world of uncertainty

What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation? Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by guest speakers Debbie Morgan (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS Foundation Trust), Ellen Rule (Deputy CEO/Director of Strategy & Transformation, Gloucestershire Integrated Care Board) and Dr Viren Mehta (GP Partner, GP Federation Chief Officer, Viaduct Care). Together we explored what all this uncertainty means for NHS decision-making, day-to-day operations, strategy, and engagement with industry. In this webinar, we bring together leaders from across the NHS to explore how they are planning and operating in this uncertainty. We explore: Strategy and planning in these times of uncertainty What’s happening with GP contracts Financial pressures and challenges If/where it’s possible to drive forward change in the current environment How Pharma and Medtech can best support NHS leaders Where the panel would welcome solutions from industry Please note this webinar was broadcast live in January 2024. Some aspects of policy discussed have evolved and continue to evolve. Discover more at: https://mtechaccess.co.uk/nhs-policy-... Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insi... Jump to: 00:00 - Welcome and introductions 04:50 - Impact of late operation plan on planning in the NHS 14:57 - Decision making and opportunities 15:20 - Opportunities for Medtech 24:00 - Innovation needs in primary care 29:08 - Difficulties in managing prescribing budgets 30:00 - Areas for cost saving in primary care 32:51 - How can companies best demonstrate value? 44:03 - Patient activation and empowerment 45:35 - Showing a case for change 50:04 - ICB needs from industry; and health innovation networks 56:40 - Final thoughts from the panel